SynCardia Announces Promotion of Don Webber to CEO & Appointme... - 04 April 2019 01:17

TUCSON, Arizona, April 4, 2019 /PRNewswire-AsiaNet/ -- -- SynCardia continues commitment to invest in their executive leadership team SynCardia Systems, LLC ( https://c212.net/c/link/?t=0&l=en&o=2423062-1&h=634201000&u=https%3A%2F%2Fsyncardia.com%2F&a=SynCardia+Systems%2C+LLC ), manufacturer of ...

  Inovio's Novel HPV Therapy INO-3106 Demonstrates Clinical Effi... - 04 April 2019 00:00

PLYMOUTH MEETING, Pennsylvania, April 3, 2019 /PRNewswire-AsiaNet/ -- -- Clinical Data Presented at Annual Meeting of American Association for Cancer Research Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced its novel therapy INO-3106 against the human papilloma virus type 6 (HPV 6) demonstrated clinica...

  Jean-Baptiste Agnus Joins Ajinomoto Bio-Pharma Services' Globa... - 03 April 2019 21:00

SAN DIEGO and WETTEREN, Belgium, April 3, 2019 /PRNewswire-AsiaNet/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading global provider of bio-pharmaceutical contract development and manufacturing services, is pleased to announce that Jean-Baptiste Agnus has joined Aji Bio-Pharma as Vice President of Sales...

  Harvest One Announces New Satipharm Supply Agreement - 03 April 2019 14:26

VANCOUVER, British Columbia, April 3, 2019 /PRNewswire-AsiaNet/ -- -- Agreement with Health House for supply of Satipharm CBD Gelpell(R) Capsules throughout Australia, New Zealand and Asia Harvest One Cannabis Inc. ("Harvest One" or the "Company") (TSXV: HVT; OTCQX: HRVOF), through it's wholly-owned subsidi...

  Inovio Presents Cancer Killing Data of Its Transformative DNA-... - 02 April 2019 22:45

PLYMOUTH MEETING, Pennsylvania, April 2, 2019 /PRNewswire-AsiaNet/ -- -- Data demonstrates tumor-clearing ability of Inovio's dBiTE technology in preclinical cancer model Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today the company's novel DNA-Encoded Bi-specific T Cell Engagers (dBiTEs(TM)) generated p...

  Young Living Celebrates 25 Years of Global Growth - 02 April 2019 05:12

LEHI, Utah, April 2, 2019 /PRNewswire-AsiaNet/ -- - Young Living looks back at two-and-a-half decades of major milestones and skyrocketing success Young Living Essential Oils ( https://c212.net/c/link/?t=0&l=en&o=2420597-1&h=3647388433&u=https%3A%2F%2Fwww.youngliv...

  Inovio Completes Enrollment Ahead of Schedule In Immuno-Oncolo... - 01 April 2019 22:45

PLYMOUTH MEETING, Pa., April 1, 2019 /PRNewswire-AsiaNet/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that its Phase 1/2 immuno-oncology trial in patients with newly diagnosed glioblastoma (GBM) has completed its enrollment three months ahead of schedule. The 52-patient trial is designed t...

  Micreos Raises Euro 30 Million for Endolysin Technology Set to... - 29 March 2019 11:52

THE HAGUE, Netherlands, March 29, 2019 /PRNewswire-AsiaNet/ -- Funding for clinical development program XZ.700 and Gladskin Eczema USA launch Dutch biotechnology company Micreos announced it has secured Euro30 million in funding to accelerate the development of its endolysin technology, set to replace ant...

  Jubilant Biosys is First to add ForteBio's Latest SPR System i... - 28 March 2019 21:23

BENGALURU, India and SAN JOSE, California March 28, 2019 PRNewswire-AsiaNet/ - Jubilant Biosys, a subsidiary of Jubilant Life Sciences Ltd, announced today that it has added advanced Pioneer FE system to its platform of drug discovery solutions available to customers. The Pioneer FE system from ForteBio, the Biologics Busine...

  Kazia to present on Cantrixil at American Association for Canc... - 25 March 2019 17:31

SYDNEY, March 25, 2019 /PRNewswire-AsiaNet/ -- Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) has been selected to present data from the Phase I study of Cantrixil in ovarian cancer at the American Association for Cancer Research (AACR) 2019 Annual ...